Assessment of antibiotic resistance rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated in intensive care units between 2014 and 2017

Aim: Non-fermenter microorganisms are commonly found in hospital environments and the treatment of infections caused by these pathogens is becoming difficult due to increasing resistance developing against antimicrobials. This study aimed to identify the resistance status of Pseudomonas aeruginosa and Acinetobacter baumannii isolates against a variety of antimicrobial agents. Clinical samples taken from patients admitted to the adult intensive care units of Ordu University Education and Research Hospital. Material and Methods: Antibiogram results for 162 P.aeruginosa and 380 A.baumannii isolates obtained from a variety of clinical samples taken from the intensive care units from January 2014 to December 2017 were retrospectively assessed. The definition of the isolates and antimicrobial susceptibility tests were studied with a VITEK 2 Compact system.Results: At our hospital, the two bacteria were most commonly isolated in respiratory tract samples. The second-highest incidence for P.aeruginosa was in urine samples and for A.baumannii strains was in blood samples. The resistance rates of P.aeruginosa strains were observed to reduce in the last two years and this change was statistically significant for cefepime, imipenem, meropenem and ciprofloxacin. There was no change in the resistance of A.baumannii strains to antibiotics used routinely during the years.Conclusion: P.aeruginosa and A.baumannii have high antibiotic resistance and are microorganisms that rapidly develop resistance during treatment. As resistance development may vary in each hospital, determination of resistance phenotype in each center will be an indicator in terms of being able to administer effective and appropriate treatment.

PDF

___

1. Nafziger DA, Lundstrom T, Chandra S, et al. Infection control in ambulatory care. Infect Dis Clin North Am 1997;11:279-96.
2. Brusselaers N, Vogelaers D, Blot S. The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care 2011;1:47.
3. Mehrad B, Clark NM, Zhanel GG, Lynch JP, 3rd. Antimicrobial resistance in hospital-acquired gram-negative bacterial infections. Chest 2015;147:1413-21.
4. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001;47:247-50.
5. Richet H, Fournier PE. Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide. Infect Control Hosp Epidemiol 2006;27:645-6.
6. Alp E. Surveillance methods. Turk J ICU 2007;5:35-6.
7. Ding JG, Sun QF, Li KC, et al. Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007. BMC Infect Dis 2009;9:115.
8. Karlowsky JA, Draghi DC, Jones ME, et al. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the united states, 1998 to 2001. Antimicrob Agents Chemother 2003;47:1681-8.
9. Demirdal T, Şen P, Yula E, ve ark. Yoğun bakım ünitelerinden izole edilen Pseudomonas aeruginosa suşlarının direnç profilleri: Beş yıllık değerlendirme. Ortadoğu Tıp Dergisi. 2017;9:108-12.
10. Dündar D, Tamer GS. Çeşitli klinik örneklerden izole edilen Pseudomonas aeruginosa suşlarının antimikrobiyal direnci: Üç yıllık değerlendirme. Ankem Derg 2009;23:17-21.
11. Şafak B, Kılınç O, Tunç N, ve ark. Türkiye’de bir devlet hastanesinde 2010-2016 yılları arasında Pseudomonas aeruginosa antimikrobiyal duyarlılık sonuçları. ANKEM Derg 2018;31:31-6.
12. Eroğlu C, Ünal N, Karadağ A, et al. Acinetobacter species isolated from various clinical specimens between 2006-2011 years and their susceptibilities against antibiotics. Turk Hij Den Biyol Derg 2016;73:25-32.
13. İnce N, Geyik MF, Özdemir D, et al. A Comparison of the Antibiotic Susceptibility Rates of Pseudomonas aeruginosa Strains Causing Hospital Acquired Infections According to Years. ANKEM Derg 2014;28:94-9.
14. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2015. Stockholm: ECDC 2017.
15. Slekovec C, Robert J, Trystram D, et al. Pseudomonas aeruginosa in French hospitals between 2001 and 2011: back to susceptibility. Eur J Clin Microbiol Infect Dis 2014;33:1713-7.
16. Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect 2016;22:9-14.
17. Uzun B, Güngör S, Sezak N, ve ark. Yoğun bakım hastalarının kan kültürlerinden izole edilen Pseudomonas aeruginosa ve Acinetobacter baumannii izolatlarının antibiyotik direnç yüzdelerindeki değişim. Turk Hij Den Biyol Derg 2014;71:1-8.
18. Hombach M, Bloemberg GV, Bottger EC. Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. J Antimicrob Chemother 2012;67:622-32.
19. Yuce A, Yapar N, Kutsoylu OE. Evaluation of Antibiotic Resistance Patterns of Pseudomonas aeruginosa and Acinetobacter Spp. Strains Isolated from Intensive Care Patients between 2000-2002 and 2003-2006 Periods in Dokuz Eylul University Hospital, Izmir. Mikrobiyol Bul 2009;43:195-202.
20. Xia WY, Chen Y, Mei YN, et al. Changing trend of antimicrobial resistance among pathogens isolated from lower respiratory tract at a university-affiliated hospital of China, 2006-2010. J Thorac Dis 2012;4:284-91.